Vaccinogen Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
Cost of Goods Sold (COGS) incl. D&A
6,802.20
6,813.10
6,727.40
6,755.10
Gross Income
6,802.20
6,813.10
6,727.40
6,755.10
SG&A Expense
4,545.80
4,286.90
9,855.80
8,076.30
EBIT
11,348.00
11,100.00
16,583.30
14,831.40
Unusual Expense
-
1,281.90
5,934.90
7,753.70
Interest Expense
176.50
312.30
2,062.40
1,210.80
Pretax Income
11,524.50
12,694.20
24,580.50
8,288.60
Consolidated Net Income
39,192.10
29,212.30
24,580.50
8,526.80
Net Income
39,192.10
29,212.30
24,580.50
8,526.80
Net Income After Extraordinaries
39,192.10
29,212.30
24,580.50
8,526.80
Net Income Available to Common
39,192.10
29,212.30
24,580.50
8,526.80
EPS (Basic)
3.27
1.48
0.79
0.50
Basic Shares Outstanding
12,003.50
19,686.80
31,089.10
32,760.50
EPS (Diluted)
3.27
1.48
0.79
0.50
Diluted Shares Outstanding
12,003.50
19,686.80
31,089.10
32,760.50
EBITDA
4,545.80
4,286.90
9,855.80
8,076.30
Other After Tax Income (Expense)
27,667.60
16,518.20
-
-
About Vaccinogen
View Profile
